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Actin dynamics provides membrane tension to
merge fusing vesicles into the plasma membrane
Peter J. Wen1,*, Staffan Grenklo2,3,*, Gianvito Arpino1,2, Xinyu Tan4, Hsien-Shun Liao5, Johanna Heureaux4,
Shi-Yong Peng1, Hsueh-Cheng Chiang1,w, Edaeni Hamid1, Wei-Dong Zhao1, Wonchul Shin1, Tuomas Na¨reoja2,
Emma Evergren2,w, Yinghui Jin1, Roger Karlsson3, Steven N. Ebert6, Albert Jin5, Allen P. Liu4, Oleg Shupliakov2,7
& Ling-Gang Wu1
Vesicle fusion is executed via formation of an O-shaped structure (O-proﬁle), followed by
closure (kiss-and-run) or merging of the O-proﬁle into the plasma membrane (full fusion).
Although O-proﬁle closure limits release but recycles vesicles economically, O-proﬁle
merging facilitates release but couples to classical endocytosis for recycling. Despite its
crucial role in determining exocytosis/endocytosis modes, how O-proﬁle merging is mediated
is poorly understood in endocrine cells and neurons containing smallB30–300 nm vesicles.
Here, using confocal and super-resolution STED imaging, force measurements, pharmacology
and gene knockout, we show that dynamic assembly of ﬁlamentous actin, involving ATP
hydrolysis, N-WASP and formin, mediates O-proﬁle merging by providing sufﬁcient plasma
membrane tension to shrink the O-proﬁle in neuroendocrine chromafﬁn cells containing
B300nm vesicles. Actin-directed compounds also induce O-proﬁle accumulation at lamprey
synaptic active zones, suggesting that actin may mediate O-proﬁle merging at synapses.
These results uncover molecular and biophysical mechanisms underlying O-proﬁle merging.
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V
esicle fusion releases vesicular contents such as hormones,
peptides and transmitters, to mediate many biological
processes crucial to an animal’s life, such as stress
responses, mood changes, synaptic transmission, neuronal net-
work activity, and immune responses1–4. It is executed via
formation of an O-shape intermediate structure, termed
O-proﬁle, at the plasma membrane for releasing contents,
followed by closure (called kiss-and-run) or merging of the
O-proﬁle into the plasma membrane (called full fusion)1–4.
O-proﬁle closure limits vesicular content release and cargo
delivery, but recycles vesicles economically1,2. In contrast,
O-proﬁle merging allows for rapid, complete content release and
cargo delivery, but couples exocytosis to classical endocytosis
involving membrane invagination, O-proﬁle formation and ﬁssion,
for retrieving merged vesicles1–3. In other words, O-proﬁle
merging deﬁnes the mode of fusion (full fusion versus kiss-and-
run) and the mode of endocytosis (classical endocytosis versus
kiss-and-run). Despite these fundamental roles, the mechanism
underlying O-proﬁle merging is unclear in endocrine cells and
neurons where vesicles are rB300 nm and fusion takes place
rapidly after calcium inﬂux. O-proﬁle merging is often assumed to
be a passive, automatic process with no energy consumption once
fusion pore opens in neurons and neuroendocrine cells.
O-proﬁle merging has recently been studied in secretory cells
containing extremely large vesicles (B1-5 mm), such as in
Xenopus oocytes5, human endothelial cells, lacrimal epithelial
acinar cells6, parotid and pancreatic acinar cells7,8, and type II
pneumocytes9, where O-proﬁle merging and release take
extremely long time (tens of seconds to tens of minutes) and
release is not as tightly coupled to calcium inﬂux as in
neuroendocrine cells and neurons (reviewed in ref. 10). These
studies suggest that cytoskeletal ﬁlamentous actin (F-actin) may
coat the fusing O-proﬁle in a few to tens of seconds after fusion,
which may mediate two seemingly opposite functions: to
compress the fusing O-proﬁle and thus to merge the O-proﬁle
with the plasma membrane, or to hold the O-proﬁle from
collapsing into the plasma membrane. Whether and which of
these mechanisms apply to endocrine cells and neurons
containing smaller vesicles remain unclear, mostly due to
difﬁculty of detecting the very transient process of O-proﬁle
merging in smaller vesicles.
In the present work, we overcame the difﬁculty of detecting
O-proﬁle merging in smaller vesicles by confocal imaging and
super-resolution stimulated emission depletion (STED) imaging
in neuroendocrine chromafﬁn cells11 and by electron microscopy
(EM) at lamprey synapses. Combined with pharmacological tools
and gene knockout (KO), we found that dynamic assembly of
cytoskeletal F-actin is necessary for O-proﬁle merging in
chromafﬁn cells. With imaging and manipulations of plasma
membrane mechanical forces, our results suggest that F-actin
mediates O-proﬁle merging by providing sufﬁcient tension at the
plasma membrane to shrink the O-proﬁle. We also found that the
F-actin assembly pathway including hydrolysis of the energy
molecule ATP, neuronal Wiskott–Aldrich syndrome protein (N-
WASP) and formin that activate F-actin assembly participates in
mediating O-proﬁle merging. F-actin-mediated O-proﬁle merging
is probably applicable to synapses, because block of F-actin led to
accumulation of O-proﬁles at the active zone of lamprey giant
synapses. These results uncover novel molecular and biophysical
mechanisms underlying O-proﬁle merging in neuroendocrine
cells and neurons, which mediates full fusion and couples
exocytosis to classical endocytosis.
Results
Imaging in conditions that facilitate X-proﬁle merging. We
used a recently developed technique to image O-proﬁle merging
in live, primary-cultured bovine adrenal chromafﬁn cells
containing B300 nm dense-core vesicles in a bath solution
containing membrane-impermeable Alexa Fluor 647 (A647) and
Alexa Fluor 488 (A488) (Fig. 1a)11. Cells were voltage clamped at
 80mV and stimulated with 10 pulses of 50ms depolarization
to þ 10mV at 2Hz (Train2Hz). The resulting calcium current
(ICa) and capacitance increases that reﬂect fusion were whole-cell
recorded (Fig. 1b). During and within 3 s after Train2Hz, A647
and A488 spots reﬂecting dye-ﬁlled fusion-generated O-proﬁles
appeared11 (Fig. 1c–f).
Consistent with our previous ﬁndings using a 1 s depolariza-
tion11, O-proﬁles may change in seven patterns (Supplementary
Fig. 1a), which are grouped into three categories (Fig. 1c) as
follows: (1) the O-proﬁle shrinks until undetectable, leading to
O-proﬁle merging with the plasma membrane, termed O-shrink
fusion; (2) the O-proﬁle is maintained while its size may remain
unchanged, enlarged or shrink to some extent, termed stay fusion;
and (3) the stay fusion is followed by pore closure, termed close
fusion11. With confocal imaging of A647 and A488 (every
20–40ms) at the cell bottom using strong and weak excitation,
respectively (confocal A647strong/A488weak setting)11, O-shrink
was identiﬁed as parallel decay of A647 and A488 spot
ﬂuorescence (F647 and F488, respectively) to baseline, whereas
A647 (or A488) spot size, measured from the full-width half-
maximum (WH), reduced until below confocal resolution (Fig. 1d
and Supplementary Fig. 1b,c; for detail, see ref. 11). Stay fusion
was identiﬁed as the persistence of the A647 and A488 spot for
430 s (our recording time; Fig. 1e). During stay fusion, the spot’s
WH may remain unchanged, reduce to some extent or enlarge,
whereas F647 and F488 changed in parallel (Supplementary Fig. 1d;
for detail, see ref. 11). Close fusion was reﬂected as stay fusion
followed by bleaching of the spot F647 to baseline, but no change
of F488 signal (Fig. 1f and Supplementary Fig. 1e), because pore
closure prevented exchange of bleached A647 (due to strong
excitation) with ﬂuorescent A647 in the bath, resulting in the
decay of the spot F647, but not the weakly excited F488 (ref. 11).
These three categories were conﬁrmed with several other
methods, including high-resolution STED microscopy (for
example, Supplementary Fig. 1c)11.
With 1 s depolarization, we previously found that O-shrink
fusion percentage increases as ICa decreases11. To search for
stimulation protocols that facilitate O-shrink fusion, we decreased
ICa charge by reducing the depolarization duration to 50ms. To
induce more granule fusion, we used 10 pulses of 50ms
depolarization at 2Hz (Train2Hz). With Train2Hz, 68±4% of
fusion events were O-shrink fusion, 29±3% were stay fusion and
3±2% were close fusion (Fig. 1g,h; n¼ 18 cells, total fusion spots:
192; ±indicates s.e. throughout this study). Similarly, whole-cell
dialysis of 1.5 mM free calcium induced mostly O-shrink fusion
(Fig. 1i). Throughout this study, we used Train2Hz to induce
fusion if not mentioned otherwise.
Dynamic F-actin assembly mediates X-proﬁle merging.
Application of latrunculin A (Lat A, 3 mM, bath), which disrupted
F-actin polymerization12, reduced O-shrink fusion from 68 to
19% (13 cells), increased stay fusion from 29 to 76%, but did not
affect close fusion (Fig. 2a,b). The remaining O-shrink fusion in
the presence of Lat A had a longer F647 decay time constant
(t, 2.8 s, for example, Fig. 2c; summarized in Fig. 2d) than in
control (1.2 s, for example, Fig. 1d,g), indicating a reduction in
O-proﬁle shrinking rate. Thus, Lat A slows down or blocks
O-proﬁle shrinking. The percentage decrease in O-shrink fusion
was mirrored by the increased stay fusion percentage (Fig. 2b),
indicating that Lat A converts O-shrink to stay fusion. Similarly,
another actin polymerization inhibitor cytochalasin D (Cyto D,
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4 mM, bath)13,14 inhibited O-shrink and increased stay fusion,
suggesting that actin polymerization mediates O-proﬁle merging
(Fig. 2b,d and Supplementary Fig. 2). As expected12–14, Lat A and
Cyto D signiﬁcantly reduced F-actin labelled with overexpressed
Lifeact-TagGFP2 (Lifeact) at the cell bottom where we examined
fusion (Fig. 2e,f).
Similar to Lat A/Cyto D, wiskostatin (10 mM), which inhibits
N-WASP-mediated, Arp2/3-dependent F-actin assembly15, and
SMIFH2 (25 mM), which blocks formin-proﬁlin binding involved
in formin-dependent F-actin assembly16, inhibited O-shrink and
promoted stay fusion (Fig. 2g). In contrast, nocodazole, a
microtubule assembly blocker, had no effects (n¼ 9 cells,
10 mM). These results suggest that F-actin assembly pathways
are involved in mediating O-proﬁle merging. Interestingly,
whole-cell dialysis of phalloidin–ﬂuorescein isothiocyanate
(FITC; 1.3 mM, 2-3min), which stabilizes F-actin, inhibited
O-shrink fusion, promoted stay fusion (Supplementary Fig. 3a,b),
but did not affect the Lifeact intensity at the cell bottom
(Supplementary Fig. 3c,d). These results suggest that dynamic
F-actin polymerization is needed to mediate O-proﬁle merging.
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Figure 1 | Train2Hz induces three fusion forms with X-shrink as the dominant form in control chromafﬁn cells. (a) Schematic drawing of a cell on the
coverslip bathed with a solution containing A647 (red) and A488 (green). ICa and membrane capacitance (Cm) are whole-cell recorded and the cell
bottom is imaged confocally. (b) Sampled ICa and the Cm change induced by Train2Hz. (c) A schematic diagram showing the O-exo-endocytosis model,
where the fusion-generated O-proﬁle may stay at the site (stay fusion), close the pore (close fusion) or shrink until undetectable (O-shrink fusion). For stay
and close fusion, the O-proﬁle may change in sizes (drawing of different sizes of O-proﬁles). Examples of O-shrink (d), stay (e) and close (f) fusion induced
by Train2Hz: F647 (red), F488 (green), WH measured from A647 (red) or A488 (green) spot and sampled images (4–15 frame average, A647, red; A488,
green, lower) at times indicated (lines) are plotted versus time. Images were collected every 20–40ms at the confocal cell-bottom setting (A647 excited
strongly; A488 excited weakly). F647 or F488 was normalized to its mean background value before spots appeared. WH was taken before the spot was too
dim to measure. The images were obtained at the cell bottom. These settings apply to all similar plots in Figs 1–4. (g) An example showing that O-shrink
fusion is the majority during Train2Hz in control: two neighbouring spots (1 and 2) underwent O-shrink fusion. Sampled images (lower) were taken at times
indicated by triangles below traces (upper). (h,i) Percentages (meanþ s.e.m.) of O-shrink, stay and close fusion spots induced by Train2Hz (n¼ 18 cells;
total spot number: 192; h) or whole-cell calcium dialysis (1.5mM, n¼ 23 cells, total spot number: 399; i) in control conditions.
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Consistent with dynamic F-actin assembly that requires
ATP hydrolysis17, replacing ATP with adenosine 5-(g-thio)
triphosphate tetralithium salt (ATPgS) (2mM, in the pipette
solution), a non-hydrolysable ATP analogue, inhibited O-shrink
fusion and increased stay fusion, but did not affect close
fusion (Fig. 2b and Supplementary Fig. 4a). ATPgS also slowed
down the F647 decay t during O-shrink fusion (Fig. 2d and
Supplementary Fig. 4b). Thus, ATP hydrolysis is needed to merge
O-proﬁles.
Although the O-shrink fusion frequency is inversely related to
ICa11, inhibition of O-shrink by actin-related drugs is not due to
ICa changes for two reasons. First, these drugs did not affect ICa
(Supplementary Fig. 5). Second, Lat A or Cyto D inhibited
O-shrink and promoted stay fusion induced by whole-cell
calcium dialysis, a stimulus independent of ICa (Supplementary
Fig. 6).
To strengthen our conclusion, we studied how O-proﬁle
merging is affected when a major actin isoform, b-actin (encoded
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2mM ATP in the pipette; n¼ 19 cells, 213 spots; ***Po0.001). Cell numbers are also shown on top of the bar (apples to other similar bar graphs). Error
bars indicate s.e.m. (c) A A647/A488-ﬁlled spot undergoing O-shrink fusion in the presence of Lat A: F647 (red), F488 (green), WH measured from A647
(red) or A488 (green) spot and sampled images at times indicated (lines) are plotted versus time. Images were obtained at the cell bottom with confocal
microscopy. Shrinking rate is slower compared with control in Fig. 1d,g. (d) F647 decay t (meanþ s.e.m.) for O-shrink fusion in control (n¼ 130 spots), in
the presence of Lat A (n¼ 33 spots, ***Po0.001), Cyto D (n¼ 20 spots, **P¼0.0016) or ATP-gS (n¼ 70 spots, *P¼0.0363). (e) Sampled Lifeact images
at the cell bottom before (0 s, left) and 600 s after (right) application of Lat A (3 mM) or a control (Ctrl) solution. (f) Lifeact-TagGFP2 ﬂuorescence (FLifeact,
mean±s.e.m.) at the cell bottom before (time 0) and during application of a control solution (Ctrl, 11 cells), Lat A (3 mM, 6 cells) or Cyto D (4mM, 6 cells).
FLifeact was normalized to the value at time 0. (g) Percentages (meanþ s.e.m.) of Train2Hz-induced spots undergoing O-shrink, stay or close fusion in control
(Ctrl, same as Fig. 1h) or in the presence of 10mM wiskostatin (n¼ 18 cells; total spot number: 175; ***Po0.001) or 25mM SMIFH2 (n¼ 8 cells; 74 spots;
***Po0.001) in the bath solution. Statistical test for b, d and g was Student’s t-test.
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by Actb gene)18, is knocked out. KO was achieved by breeding
chromafﬁn cell-speciﬁc Cre mice, the PNMTCre/þ mice19, with
ActbLoxP/LoxP mice20 and subsequently breeding PNMTCre/þ ;
ActbLoxP/þ mice with PNMTCre/þ ; ActbLoxP/þmice to
generate PNMTCre/Cre; ActbLoxP/LoxP mice (Actb / mice;
Supplementary Fig. 7). Immunostaining of Cre and b-actin
conﬁrmed expression of Cre-recombinase and the absence of
b-actin in Actb / mouse chromafﬁn cells (Fig. 3a).
In cultured wild-type (WT) or ActbLoxP/LoxP mouse chromaf-
ﬁn cells (control), Train2Hz induced an ICa of 416±55 pA and a
capacitance jump (n¼ 10 cells; Supplementary Fig. 8a). Fusion
events included O-shrink fusion (80±5%), stay fusion (18±5%)
and close fusion (2±1%) as recorded at the confocal A647strong/
A488weak setting (Supplementary Fig. 8b–e; n¼ 10 cells, total
fusion spots: 80). Similar percentages of O-shrink, stay and close
fusion were induced by whole-cell dialysis of calcium (1.5mM)
into the chromafﬁn cells (Fig. 3b). These results were similar to
those observed in control bovine chromafﬁn cells. We used
calcium dialysis as stimulation for most mouse experiments,
because calcium dialysis induced more fusion events.
b-Actin KO reduced O-shrink from 77% in control to 25% and
increased stay fusion from 20 to 74%, but did not affect close
fusion during calcium dialysis (Fig. 3b). Similar reduction of
O-shrink fusion and increase of stay fusion were obtained during
Train2Hz in Actb / mouse chromafﬁn cells (Supplementary
Fig. 8e). Rescue of KO by transfecting WT b-actin attached with
monomeric enhanced green ﬂuorescent protein (b-Actin–
mEGFP, for recognition of transfected cells) to Actb / cells
increased b-actin expression (Fig. 3c; n¼ 3 transfections) and
rescued O-shrink fusion to the control level (Fig. 3b; n¼ 7 cells).
Thus, b-actin is involved in mediating O-proﬁle merging.
Application of Lat A (3 mM) in Actb / cells did not further
reduce O-shrink fusion (Fig. 3b; n¼ 7 cells), but signiﬁcantly
reduced O-shrink fusion in WT cells (Fig. 3b; n¼ 10 cells),
conﬁrming that Lat A reduces O-shrink fusion by blocking
F-actin. These results consolidated our conclusion that actin is
involved in mediating O-shrink fusion.
F-actin is more concentrated near the plasma membrane.
Recent studies show that in cells containing B1–5 mm granules,
F-actin coats the fusing O-proﬁle with an onset at several seconds
after fusion, which is thought to either compress or hold the
O-proﬁle5–10. Here we determined whether F-actin coats and
shrinks the fusing O-proﬁle in chromafﬁn cells. STED scanning at
the microscopic XY plane above the cell bottom (4 2 mm)
revealed that dense Lifeact co-localized with or near the
overexpressed phospholipase C delta PH domain tagged with
mPapaya (PH–mPapaya), which labels PtdIns(4,5)P2 (PIP2),
a lipid localized at the plasma membrane (Fig. 4a)21. STED
scanning at the microscopic XZ plane (vertical to XY plane,
parallel to microscopic Z axis) at the cell bottom revealed that
Lifeact closely adhered to the PH–mPapaya (Fig. 4b), conﬁrming
a dense cortical actin network observed near, but not far from,
the plasma membrane (see also Supplementary Fig. 9a,b for
quantiﬁcation)22–24. With this dense actin network, granules near
the plasma membrane, including NPY–mCherry-containing
granules, were more associated with the F-actin network than
those far from the plasma membrane (Fig. 4c), similar to a recent
report with three-dimensional electron tomography24. We did
not observe consistently actin rings surrounding NPY–EGFP-
containing vesicles (Fig. 4c).
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Confocal imaging revealed that in 41% (15 out of 37) of
O-shrink fusion events, as F647 decayed due to O-proﬁle
shrinking, FLifeact increased at the spot centre (Supplementary
Fig. 9c,d), suggesting F-actin movement or coating of the
shrinking O-proﬁle. However, the onset of FLifeact increase was
1.9±0.4 s (n¼ 15) later than the onset of F647 decay that reﬂected
O-proﬁle shrinking (Supplementary Fig. 9c,d). FLifeact increase
started when F647 decreased by 57±5% (n¼ 15; Supplementary
Fig. 9c,d). This delayed FLifeact increase suggests that F-actin
movement or coating does not initiate O-proﬁle shrinking. More
importantly, 59% (22 out of 37) of O-shrink fusion events were
not accompanied with FLifeact increase (Supplementary Fig. 9e,f).
This lack of FLifeact increase was not due to the lack of Lifeact
expression, because (1) Lifeact was expressed nearby O-shrink
events showing no FLifeact increase (for example, Supplementary
Fig. 9e) and (2) 15 out of 22 O-shrink events showing no FLifeact
increase were observed in cells containing other O-shrink
fusion events with FLifeact increase. Thus, O-proﬁle shrinking
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with a focal plane42 mm above the cell bottom. Left and middle panels are superimposed in the right panel. (b) STED XZ imaging of PH–mPapaya (upper)
and Lifeact-TagGFP2 (middle) at the cell bottom. Upper and middle images are superimposed in the lower panel. (c) Sampled STED images of a cell
overexpressing NPY–mCherry (upper, red) and Lifeact (middle, green) at the cell bottom, at the XZ scanning mode. Upper and middle panels are
superimposed in the lower panel. (d) Lat A reduces cell surface tension. Left: drawings of micropipette aspiration technique. A negative pressure (DP) on
the pipette (with a diameter D) draws the cell membrane into the pipette by a length L. Right: pipette-aspirated cells (bright-ﬁeld images) in the absence
(Ctrl) and presence of Lat A (0.5 mM). Arrows, membrane projection (L) in the micropipette (DP¼ 500Pa). (e) Normalized projection length (L/D,
meanþ s.e.m.) for aspirated cells in the absence (Ctrl, n¼ 10 cells) or presence of Lat A (0.5mM, n¼8 cells; *P¼0.011; unpaired two-tailed Student’s
t-test). DP¼ 500Pa. (f) Three-dimensional (3D) images of a chromafﬁn cell in control (Ctrl, 305mOsm), in a hyper-osmotic solution (650mOsm, Hyper)
and a hypo-osmotic solution (164mOsm, Hypo). The image was obtained with atomic force microscopy. (g) Chromafﬁn cell volume (meanþ s.e.m.) in
Ctrl, Hyper (n¼ 5 cells, *P¼0.03, paired two-tailed Student’s t-test) or Hypo solution (n¼4 cells, *P¼0.016, paired two-tailed Student’s t-test) computed
from atomic force microscopic 3D images. Hyper and Hypo data were normalized to the Ctrl (305mOsm).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12604
6 NATURE COMMUNICATIONS | 7:12604 | DOI: 10.1038/ncomms12604 |www.nature.com/naturecommunications
takes place regardless of whether F-actin moves into the
shrinking O-proﬁle or not, suggesting that O-proﬁle shrinking
does not require F-actin recruitment to the shrinking
O-proﬁle.
We do not know why F-actin moves into the shrinking
O-proﬁle in some cases. It could be either a passive reﬁlling of the
empty space or an active process. Further understanding of this
phenomenon is beyond the scope of the present work, which
aimed at understanding the mechanisms underlying O-shrink
fusion.
F-actin exerts mechanical forces to merge the X-proﬁle. F-actin
increases the plasma membrane tension (Tensionpm)25–28. Here
we tested whether F-actin shrinks the O-proﬁle via an increase of
Tensionpm. We estimated Tensionpm, the force needed to pull the
surface by certain length (force per unit length), using the
micropipette aspiration technique. A negative pressure applied to
a micropipette in contact with the plasma membrane drew the
plasma membrane into the pipette to a length L (Fig. 4d)29. The
normalized length, calculated as L divided by the pipette diameter
D (L/D), is inversely correlated with Young’s module, a
membrane elasticity measurement that is correlated with
Tensionpm29. With a negative pressure of 500 Pa, the L/D value
was B2 times larger in the presence of Lat A than in control
(Fig. 4d,e), suggesting that Lat A reduces membrane stiffness and
Tensionpm in chromafﬁn cells.
To determine whether reduction of Tensionpm inhibits
O-shrink fusion, we changed Tensionpm with a commonly used
method—increasing or reducing the bath solution osmolarity to
reduce or increase Tensionpm, respectively25,28. Consistent with
reduced Tensionpm, increasing osmolarity from 305 (control) to
650mOsm (hyper-osmotic solution) reduced the cell volume,
measured with atomic force microscopy (AFM; Fig. 4f,g). It also
reduced the cell diameter, detected by confocal microscopy at the
cell-centre with A647 in the bath (Supplementary Fig. 10a).
Consistent with enhanced Tensionpm25,28, reducing the bath
osmolarity from 305 to 164mOsm (hypo-osmotic solution)
increased the cell volume (Fig. 4f,g) and diameter (Supplementary
Fig. 10b), and increased Tensionpm estimated with micropipette
aspiration (n¼ 10 cells, not shown).
Resembling actin blockers, the hyper-osmotic solution
decreased O-shrink fusion induced by Train2Hz from 68 to 23%
and increased the stay fusion from 29 to 75% (Po0.001; Fig. 5a).
Adding Lat A to a hyper-osmotic solution did not further reduce
O-shrink or increase the stay fusion percentage (Fig. 5a),
suggesting that Lat A inhibited O-shrink fusion primarily by
reducing Tensionpm.
Compared with control, the hypo-osmotic solution did not
further increase the O-shrink fusion or decrease stay fusion
(Fig. 5b), probably because O-shrink fusion has already
approached its maximal capacity (B70%) in control. However,
in the presence of Lat A, applying the hypo-osmotic solution
increased O-shrink fusion from 19 to 50% (Po0.001; t-test),
decreased stay fusion from 76 to 48% (Po0.001; t-test, 18 cells;
Fig. 5b) and did not affect ICa (Supplementary Fig. 11). This
rescue of O-shrink fusion by a large extent (Fig. 5b) suggests that
the increase in Tensionpm by the hypo-osmotic solution counter-
acts Lat A’s inhibitory effects on O-shrink fusion.
In summary, Lat A reduced Tensionpm (Fig. 4d,e) and
O-shrink fusion percentage (Fig. 2b). Reducing Tensionpm by
the hyper-osmotic solution mimicked Lat A’s effect in inhibiting
O-shrink fusion and prevented Lat A from further inhibiting
O-shrink fusion (Fig. 5a). Conversely, enhancing Tensionpm by
the hypo-osmotic solution largely prevented Lat A from
inhibiting O-shrink fusion (Fig. 5b). These results suggest that
Lat A inhibits O-shrink fusion by reducing Tensionpm. In other
words, F-actin mediates O-shrink fusion by providing sufﬁcient
Tensionpm.
In Actb / cells, applying the hypo-osmotic solution
(221mOsm) increased O-shrink fusion from 20 to 78%
(Po0.001; t-test) and decreased stay fusion from 73 to 20%
(Po0.001; t-test, n¼ 10 cells; Fig. 5c). Applying the hypo-
osmotic solution to WT mouse chromafﬁn cells did not increase
the O-shrink fusion (Fig. 5c; n¼ 8 cells). Thus, increasing
Tensionpm by hypo-osmotic solution rescued the inhibition of
O-shrink fusion by b-actin KO, which further supports our
suggestion that actin mediates O-shrink fusion by providing
sufﬁcient Tensionpm.
How would sufﬁcient Tensionpm shrink the O-proﬁle? Given
that blocking F-actin increased stay fusion and thus the number
of O-proﬁles at the plasma membrane, there should be an
F-actin-independent force that maintains the O-proﬁle from
collapsing. With this O-proﬁle-maintaining force, Tensionpm may
pull the O-proﬁle membrane and thus shrink the O-proﬁle till
merging of the O-proﬁle with the plasma membrane (Fig. 5d).
We can now update the O-exo-endocytosis model (Fig. 1c),
where calcium and dynamin mediate close fusion11, with the
involvement of F-actin and Tensionpm in O-shrink fusion
(Fig. 5e).
F-actin blockers increase X-proﬁles at active zones. To deter-
mine whether F-actin mediates O-proﬁle merging in synapses,
we examined whether block of actin dynamics accumulates
O-proﬁles in lamprey giant reticulospinal synapses, in which
intermediates of the vesicle cycle can be clearly resolved using
EM30,31. We microinjected giant axons with a mixture of Lat A
and Cyto D or a modiﬁed proﬁlin–actin protein with a zero-
length covalent cross-link between proﬁlin and actin, termed
PxA32–34. PxA structually resembles endogeneous proﬁlin–actin,
but is non-dissociable between proﬁlin and actin, and thus
inhibits formin-dependent F-actin assembly32–34. Concentrations
of the actin-directed compounds in microinjection pipette were
60 mM per 33 mM for Lat A/Cyto D and 5mgml 1 for PxA, but
were diluted B10–20 times in the studied regions of axons
following microinjections (Supplementary Fig. 12a). The active
zone morphology (Supplementary Fig. 12b–e and Fig. 6a,b) and
the action potential progagation along the axon (Supplementary
Fig. 12f) were apparently normal after microinjection. Synapses
were stimulated with action potentials at 5Hz for 20–30min,
then ﬁxed and embedded for EM in serial ultrathin sections30,31.
Vesicle clusters were observed at active zones and examined in
serial ultrathin sections (Fig. 6a–f and Supplementary Fig. 12b–d).
O-proﬁles were identiﬁed as having a pore smaller than or equal
to its width (Fig. 6c-e). O-proﬁles were rarely observed in control
synapses or synapses microinjected with bovine proﬁlin I
(Fig. 6c,g), but were much more frequently observed at the
active zones of the synapses microinjected with Lat A/Cyto D
(Fig. 6d,g) or PxA (Fig. 6e,g). Lat A/Cyto D or PxA did not
signiﬁcantly affect the number of vesicles at the active zone
membrane (Supplementary Fig. 12b–e). Unlike clathrin-coated
O-proﬁles observed at the periactive zone (Fig. 6f)30,31, O-proﬁles
at the active zone were not coated with the clathrin lattice
(Fig. 6c-e), suggesting that they are not generated via clathrin-
mediated endocytosis. Dimension of most of O-proﬁles were
similar to vesicles, but some appeared to be larger or smaller
(for example, Fig. 6d,e and Supplementary Fig. 12b–d), consistent
with stay fusion displaying variations of O-proﬁle size in
chromaﬁn cells (Supplementary Fig. 1)11.
The O-proﬁles accumulated at the active zone are unlikely to
be due to block of the fusion pore closure, because in chromafﬁn
cells actin blockers did not block close fusion induced by Train2Hz
(Fig. 2) or a 1 s depolarization (n¼ 8 cells, 3 mM Lat A, not
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shown), the latter of which induced more close fusion events11.
Analogous to results observed in chromafﬁn cells, results observed
in lamprey axons (Fig. 6) suggest that F-actin promotes O-proﬁle
merging at active zones. This suggestion was further supported by
the following two sets of control experiments.
First, post-embedding immunoEM with a monoclonal actin
antibody12,19 revealed an accumulation of immunogold particles
around dense projections of the active zone in giant synapses
(Fig. 6h–j and Supplementary Fig. 13a–d)35. The number of gold
particles near the presynaptic plasma membrane (o100 nm)
of the active zone (95.7±15.4 mm 2; n¼ 20 synapses) was
signiﬁcantly higher than that (the particles near the presynaptic
plasma membrane) 4300 nm outside the active zone (PM
outside active zone, 16.9±5.0 mm 2; n¼ 20 synapses,
Po0.001; Fig. 6j and also see Supplementary Fig. 13a–d for
illustrations). It was also signiﬁcantly higher than in the synaptic
vesicle reserve pool area, 200 nm inside the active zone membrane
(43.5±5.0 mm 2; n¼ 17 synapses, P¼ 0.0048; Fig. 6h–j). Thus,
actin network is denser near the active zone membrane. The
dense actin network at the active zone membrane was further
conﬁrmed by confocal microscopy of F-actin labelled with
phalloidin conjugated with Alexa Flour 488 (phalloidin-Alexa
488) injected into the axon (Supplementary Fig. 14a).
Microinjected phalloidin-Alexa 488 accumulated in spots of
ﬂuorescence that labelled active and periactive zones36 (see also
Supplementary Fig. 14a).
Second, to determine whether Lat A and Cyto D reduced
F-actin, we injected Lat A/Cyto D plus Texas Red and 10–15min
later injected phalloidin-Alexa 488 into the axon at B800mm
away. Next, we measured phalloidin-Alexa 488 ﬂuorescence
punta at B300–500mm away from the Lat A/Cyto D injection
site (Supplementary Fig. 14b,c). The number of detectable puncta
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the postsynaptic density. (i) The box region in h shown at higher magniﬁcation. (j) Bar graph showing the number of actin gold particles per mm2 within
100nm from the active zone membrane, within 100nm from the presynaptic membrane, but B300nm away from the active zone (PM outside active
zone, see Supplementary Fig. 13a for an illustration of these regions), and in the reserve pool area 200nm from the active zone (n¼ 20 synapses,
meanþ s.e.m.; **Po0.01; ***Po0.001, Student’s t-test).
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was decreased by ﬁve- to tenfold in the area where compounds
intermixed and the average phalloidin-Alexa 488 punta intenstiy
was signiﬁcantly lower in Lat A/Cyto D-injected axons (43.1±5.1
arbitrary units, n¼ 15 spots, 2 axons; Supplementary Fig. 14c,d)
than in control axons injected with Texas Red only (72.8±2.0
arbitrary units, n¼ 29 spots, 2 axons; Supplementary Fig. 14b,d;
Po0.0001, two-tailed Student’s t-test), suggesting that Lat A and
Cyto D reduced F-actin in lamprey axons.
In summary, actin was localized in the active zone membrane
(Fig. 6h–j and Supplementary Figs 13 and 14). F-actin directed
compounds reduced F-actin (Supplementary Fig. 14) in the axon
and caused accumulation of O-proﬁles at the active zone
membrane (Fig. 6) without damaging the morphology and the
action potential propagation of the axon (Supplementary Figs 12
and 13). These results suggest that F-actin is involved in
mediating O-proﬁle merging at the neuronal nerve terminal.
Discussion
The present work establishes a molecular and biophysical model
accounting for O-proﬁle merging, which deﬁnes the modes of
exocytosis and endocytosis. We found that dynamic F-actin
assembly is necessary for O-proﬁle merging in chromafﬁn cells
(Figs 1–3). F-actin imaging and Tensionpm measurements and
manipulations suggest that F-actin provides sufﬁcient Tensionpm
to facilitate O-proﬁle shrinking and thus to merge the O-proﬁle
with the plasma membrane (Figs 4 and 5). Not only F-actin but
also the F-actin assembly pathway such as N-WASP, formin
(Figs 2 and 6) and ATP hydrolysis (Fig. 2) may participate in
O-proﬁle merging. The highly abundant cytoskeletal actin and its
assembly pathway, the essential energy-providing molecule ATP
and cell membrane tension controlled by many factors may thus
regulate exo- and endocytosis in physiological and pathological
conditions by controlling O-proﬁle merging.
Our ﬁndings, obtained from bovine and mouse chromafﬁn
cells containing large vesicles, may apply to many other cells
containing similarly large dense-core vesicles. They may apply to
large vesicles distributed widely in glial cells, nerve terminals,
neuronal dendrites and cell bodies that secrete dopamine,
peptides or hormones (for example, oxytocin and vasopressin)
or deliver transmembrane receptors to dendrites and dendritic
spines crucial for our brain’s physiological functions and
disorders2,37.
Our ﬁnding that F-actin mediates O-proﬁle merging is likely to
apply to small synaptic vesicles, because (1) actin blockers
accumulate O-proﬁles at lamprey active zones (Fig. 6) and (2)
neuroendocrine chromafﬁn cells and nerve terminals are similar
in the molecular machineries of exo- and endocytosis1,2,38–40. We
acknowledge that the evidence obtained with EM at lamprey
synapses was not as direct as that in live chromafﬁn cells where
O-proﬁle merging could be observed directly. The ﬁnal resolution
at live synapses, although technically not available now, will
eventually be needed to establish our conclusion for synapses.
O-proﬁle merging is via shrinking of O-proﬁle in chromafﬁn
cells11, but is generally believed to be via pore dilation
(full-collapse fusion) at synapses41–43. One may wonder how
F-actin mediates these two different behaviours. O-shrink fusion
was revealed in live cells with STED imaging at B90 nm
resolution, which could not exclude pore dilation below 90 nm11,
whereas pore dilation was suggested based on EM41–43 but has
not been visualized and proved in any live cell. O-proﬁle
shrinking and pore dilation may therefore be reconciled with a
scenario, in which O-proﬁle membrane was pulled into the
plasma membrane by Tensionpm, resulting in continuous
O-proﬁle shrinking until the height of the O-proﬁle is shorter
than the pore diameter (Fig. 5d, grey drawing). Under this
condition, further pulling of the O-proﬁle membrane into the
plasma membrane by Tensionpm results in a collapse-like
structure, turning into a full-collapse fusion (Fig. 5d). This
model requires an actin-independent mechanism to hold the
pore from collapse, which must exist because F-actin inhibition
increased stay fusion, the persistent presence of fusion-generated
O-proﬁles (Figs 2 and 3). The pore size may determine when the
merging process changes from shrinking to collapse. It would be
of great interest to test this model by visualizing the fusion pore
during shrinking of the O-proﬁle in the future.
Although inhibition of F-actin reduced O-shrink, but increased
stay fusion, close fusion did not increase (Figs 2 and 3). This
observation suggests that conversion from stay to O-proﬁle
closure is not automatic but requires a trigger. We recently found
that calcium inﬂux triggered close fusion—large calcium inﬂux
during a 1 s depolarization induce close fusion in 4 80% of
fusion events and nearly no O-shrink fusion11. Thus, large
calcium inﬂux is needed to convert stay to close fusion. This may
explain why with relatively low calcium inﬂux during Train2Hz,
increase of stay fusion in the presence of F-actin blockers did not
signiﬁcantly increase close fusion. Taken together, the extent of
calcium inﬂux determines whether the fusing O-proﬁle closes or
not (Fig. 5e). If the O-proﬁle does not close, sufﬁcient Tensionpm
provided by F-actin may mediate O-shrink fusion (Fig. 5e).
If Tensionpm is insufﬁcient, O-proﬁle stays at the plasma
membrane, resulting in the stay fusion (Fig. 5e).
With large calcium inﬂux, close fusion occurs much more often
than O-shrink fusion11. This might be in part due to inhibition of
O-shrink fusion by strong calcium inﬂux. Consistent with this
possibility, calcium inﬂux facilitates F-actin disassembly44, which
may result in reduction of O-shrink fusion (Fig. 2). It would be of
great interest to prove (or disapprove) this possibility with
experimental evidence in the future.
A large number of previous studies suggest that actin may play
several possibly overlapping roles in the fusion process, including
serving as a fusion barrier or providing a scaffold for anchoring
secretory vesicles, a track to deliver secretory vesicles to the fusion
site, regulation of vesicle docking and priming, regulation of the
fusion pore, regulation of membrane merging after fusion and
endocytosis (reviewed in ref. 45). As discussed below, the present
work suggests a new mechanism of F-actin—mediating O-proﬁle
shrinking and merging by providing sufﬁcient Tensionpm.
In Xenopus oocytes containing cortical granules5, human
endothelial cells containing Weibel–Palade bodies, lacrimal
epithelial acinar cells containing zymogen granules6, parotid or
pancreatic acinar cells containing zymogen granules7,8 and type II
pneumocytes containing lamellar body9, vesicle fusion is followed
by F-actin coating of the fusing vesicle (reviewed in ref. 10). Such
an F-actin coating has been suggested to mediate two seemingly
opposite functions: to compress the fusing O-proﬁle and thus to
expel the vesicular content, or to hold the O-proﬁle from merging
into the plasma membrane. However, these results were obtained
from vesicles (B1–5 mm in diameter), which are much larger
than those in neuroendocrine chromafﬁn cells (B300 nm) and
neurons (B20–80 nm), and take much longer time, in the order
of tens of seconds to tens of minutes, to merge the O-proﬁle and
expel vesicular contents. These substantial differences might
explain why F-actin recruitment to the fusing vesicle is not the
main mechanism to shrink the O-proﬁle in chromafﬁn cells
(Supplementary Fig. 9). Instead, F-actin provides sufﬁcient
Tensionpm (Figs 4 and 5) to mediate rapid O-proﬁle merging in
hundreds of milliseconds in chromafﬁn cells (Figs 2 and 3). It is
possible that this mechanism may also contribute to mediate
O-proﬁle merging in cells containing large 1–5 mm vesicles, given
that Tensionpm has not been considered for large vesicle fusion in
previous studies.
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F-actin blockers slow down catecholamine release46–48 and
NPY–EGFP release (Supplementary Fig. 15) in chromafﬁn cells,
suggesting that F-actin speeds up vesicular content release49. It
was suggested that F-actin may squeeze the fusing O-proﬁle to
speed up vesicular content release49. Our results suggest that the
force to expel vesicular contents may be from Tensionpm
provided by F-actin, but not from active F-actin coating of the
fusing O-proﬁle as observed during extremely slow release from
very large vesicles10. In addition to facilitating content release,
F-actin may promote dispersion of vesicular membrane proteins
by promoting O-proﬁle shrinking, because a stabilized O-proﬁle
retains vesicular membrane protein VAMP2 (ref. 11).
A previous study observed that actin-directed compounds
increase the quantal size (from amperometric measurements)
and reduce the capacitance variance48,50 in chromafﬁn cells. This
observation led to the suggestion that actin stabilizes O-proﬁles in
chromafﬁn cells containing B300 nm vesicles50. However, this
suggestion is interpreted from the measurements of quantal size
(from amperometric measurements) and capacitance variance,
which could not estimate a pore beyond B5 nm51,52 nor predict
O-proﬁle merging. By direct measurements of O-proﬁle merging,
we found that F-actin mediates O-proﬁle merging. We therefore
suggest not to interpret O-proﬁle merging based on indirect
amperometric or capacitance measurements.
Although fusion pore opening is well known to overcome a
signiﬁcant energy barrier4, once the pore is opened, the O-proﬁle
is generally considered an unstable fusion intermediate that
rapidly and passively merges with the plasma membrane without
consuming energy in endocrine cells and neurons. This view
appears to be incorrect, as we found that ATP hydrolysis and
dynamic actin polymerization are needed to merge the O-proﬁle.
The fusion-generated O-proﬁle is actually a stable structure in the
absence of ATP hydrolysis (Fig. 2). Given that O-proﬁle merging
takes place in all secretory cells1,2, O-proﬁle merging might be an
energy-consuming step previously unrecognized. As vesicle
exo- and endocytosis consume most ATP molecules in nerve
terminals53, ATP consumption in O-proﬁle merging is a factor
worth of consideration in low metabolic states with low ATP
levels, mitochondria dysfunctions in various diseases (for
example, Parkinson’s disease and Alzheimer’s disease) that
reduce ATP54 and in diseases that affect F-actin or F-actin
assembly pathways55.
Methods
Primary bovine chromafﬁn cell culture. Bovine chromafﬁn cells were prepared as
described previously11. Brieﬂy, fresh adrenal glands were obtained from a local
slaughterhouse on the day of culture. After excess fat was trimmed off the glands
(two were used per culture), glands were then perfused with cold 1 Lock’s buffer
containing (in mM): NaCl, 145; KCl, 5.4; Na2HPO4, 2.2; NaH2PO4, 0.9; glucose,
5.6; and HEPES, 10 pH 7.3, to remove any residual blood. Each gland was then
injected through the portal vein with B2ml of ﬁltered Lock’s buffer containing
collagenase P (1.5mgml 1, Roche), trypsin inhibitor (0.325mgml 1, Sigma) and
BSA (5mgml 1, Sigma), and incubated at 37 C for 20min in a water bath. The
glands were then cut open longitudinally, to expose the digested medulla. The
medulla were carefully removed, minced in Lock’s buffer and ﬁltered through a
nylon mesh. The ﬁltrate was centrifuged at 500 r.p.m. for 4–5min, to obtain the cell
pellet. The supernatant was then removed and the pellets resuspended in Lock’s
buffer. The process was repeated one to two times until the supernatant was clear.
Final cell pellet was resuspended in pre-warmed DMEM low glucose medium
(Gibco) supplemented with 10% fetal bovine serum (Gibco) and plated onto
poly-D-lysine and laminin I-coated 25mm-diameter glass coverslips (Neuvitro
Corp., USA). The plated cells were incubated at 37 C, 8% humidiﬁed CO2 and
used within 4 days after culturing. In some experiments, cells were transfected with
2 mg of Lifeact-tagGFP2 (Ibidi, Germany) by electroporation using a basic neuron
nucleofector kit (Lonza, Program O-005) according to the manufacturer’s
instruction.
Electrophysiology. Whole-cell voltage-clamp and capacitance recordings were
performed with an EPC-10 ampliﬁer together with the lock-in software (PULSE,
HEKA, Lambrecht, Germany)56. All experiments were carried out at room
temperature (21 C  24 C) with the cells immersed in bathing solution
containing (in mM): 125 NaCl, 10 glucose, 10 HEPES, 5 CaCl2, 1 MgCl2, 4.5 KCl,
0.001 tetrodotoxin and 20 tetraethylammonium ion, pH 7.3. The osmolarity of the
bath solution was 305–310mOsm. In some experiments, we increased the
osmolarity to 640–650mOsm by adding 295mM sucrose to the bath solution. In
some experiments, we decreased the osmolarity to 160–221mOsm by reducing
NaCl to 55–70mM.
The pipette (3–6MO) solution contained (in mM): 130 glutamate, 0.5 EGTA,
12 NaCl, 30 HEPES, 1 MgCl2, 2 ATP and 0.5 GTP pH 7.2 adjusted with CsOH. The
osmolarity was B308mOsm. In some experiments, ATP (2mM) in the pipette
solution was replaced with a non-hydrolysable ATPgS (2mM, Sigma) and MgCl2
was raised to 3mM to facilitate endogenous ATP turnover57. For intracellular
Ca2þ dialysis experiments, the pipette solution contained (in mM): 110 glutamate,
10 EGTA, 12 NaCl, 30 HEPES, 1 MgCl2, 2 ATP 0.5 GTP and 9 CaCl2 pH 7.2
adjusted with CsOH. The free Ca2þ concentration was B1.5 mM, which was
calculated based on the Max-Chelator programme (Stanford University, Stanford,
CA), in which the calcium dissociation constant of EGTA is 0.15 mM58,59.
The holding potential was  80mV. For Train2Hz stimulation, a Train of 50ms
depolarization from  80 to þ 10mV was given at 2Hz; each 50ms depolarization
was preceded by a 50ms pre-pulse from  80 to þ 120mV, to facilitate Ca2þ
channel current60–62. Cell membrane capacitance was simultaneously recorded 15 s
before, during and 30 s after depolarization. The sample interval for current
recordings was 50ms. The frequency of the sinusoidal stimulus was 1,000–1,500Hz
with a peak-to-peak voltage r50mV.
Confocal imaging. Alexa 647 (A647; 20–30 mM in bathing solution, Invitrogen)
and Alexa 488 dyes (A488; 20–30 mM in bathing solution, Invitrogen) were excited
by a solid-state 638 nm (30mW output) and 488 nm lasers (20mW output) with an
inverted confocal microscope (TCS SP8, Leica, Germany; original magniﬁcation,
 63/1.40 oil objective). Unless mentioned otherwise, the 638 nm laser was set at
20–25% of the maximum power and the 488 nm laser was set at 0.5–2% of the
maximum power. A647 ﬂuorescence was collected with a photomultiplier at
639–767 nm, whereas A488 was collected with a hybrid GaAsP spectral detector at
489–596 nm. For time-lapse A647/A488 imaging, images were collected with 40ms
inter-frame interval at 45–70 nm per pixel in an imaging area of B160–320mm2.
In some experiments, cells were pre-treated with 3 mM latrunculin A (Enzo Life
Sciences), 4 mM Cyto D (Enzo Life Sciences), wiskostatin (10 mM, Tocris
Bioscience) and SMIFH2 (25 mM, Tocris Bioscience) for 20min in the bath
solution, or whole-cell dialysis of phalloidin–FITC (1.3 mM, Invitrogen) for
2–3min before imaging.
STED imaging. The inverted STED microscopes used in this study (TCS SP5
STED, TCS SP8 STED 3X, Leica) have a resolution of B60–90 nm. A488 (60 mM)
was excited with an Argon laser at 488 nm at 20% of the maximum power
(maximum power: 25mW) and depleted with a continuous wave ﬁbre laser at
592 nm using the maximum power (1.5W). The ﬂuorescence was acquired by
GaAsP hybrid detection system at 498–580 nm. At 20% of the maximum power,
488 nm laser caused A488 bleaching after pore closure with a time course similar to
that of A647 under the confocal setting11. Lifeact (TagGFP2) was excited by a
tunable white light laser at 470 nm (7% of maximum power) with the STED
depletion laser at 592 nm (25% of the maximum power) and its ﬂuorescence at
480–560 nm was collected using time-gated detection (1.5–6.5 ns). mCherry was
excited by the tunable white light laser at 570 nm (6% of maximum power) with the
STED depletion laser at 660 nm (60% of the maximum power) and its ﬂuorescence
between 575 and 650 nm was collected using time-gated detection (0.5–6.5 ns).
PH–mPapaya was excited by the tunable white light laser at 530 nm (14% of the
maximum power) with the STED depletion laser at 660 nm (10% of the maximum
power) and its ﬂuorescence between 541 and 620 nm was collected using
time-gated detection (1.5–6.5 ns). When NPY–mCherry or PH–mPapaya and
Lifeact (TagGFP2) were imaged at the STED microscope, NPY–mCherry
(or PH–mPapaya) was imaged ﬁrst, to avoid bleaching of mCherry or mPapaya
ﬂuorescence by the 592 nm STED depletion laser. For XZ scanning, we used
70–80% of STED depletion laser power in the Z-direction to improve the z axis
resolution.
Image analysis. A647 or A488 spots (O-proﬁles ﬁlled with A647 or A488) were
identiﬁed during and o3 s after the end of depolarization. The spot ﬂuorescence
intensity was measured using the LAS AF Life analysis tool or Image J and plotted
using Igor Pro 6.12. The baseline ﬂuorescence value for each spot was normalized
to 1. The representative image frames shown below the ﬂuorescence traces were
either unaveraged or averaged up to 20 frames as indicated in the ﬁgure legends.
WH was measured from intensity proﬁles of two to four lines across the spot centre
at 45o or 90o apart11.
Although fusion modes (O-shrink fusion, stay and close fusion) were identiﬁed
mostly at the cell-bottom confocal A647/A488 setting (strong/weak excitation),
we sometimes identiﬁed the fusion modes with a single dye excited strongly,
as described in detail in ref. 11. A single dye was used for Actb / cells
overexpressed with b-Actin–mEGFP (Fig. 3b), for cells dialysed with
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phalloidin–FITC (Supplementary Fig. 3) and for STED imaging above the cell
bottom (Supplementary Fig. 1c; 592 nm laser for depletion).
Generation of chromafﬁn cell-speciﬁc b-actin KO mice. Global KO of b-actin is
embryonically lethal63,64. Accordingly, we used a chromafﬁn cell-speciﬁc Cre
mouse, the PNMTCre/þ mouse19, to knock out b-actin tissue speciﬁcally in
chromafﬁn cells. We bred the 129/SvImJ PNMTCre/þ mice with C57BL/6
ActbLoxPLloxP mice (Actb gene encodes b-actin)20 and subsequently bred
PNMTCre/þ ; ActbLoxP/þ mice with PNMTCre/þ ; ActbLoxP/þ mice to generate
PNMTCre/Cre; ActbLoxP/LoxP mice (Actb / mice). Mouse genotypes were
determined by PCR.
Mouse chromafﬁn cell culture. Animal care and use were carried out in
accordance with NIH guidelines and approved by NINDS/NIDCD/NCCIH Animal
Care and Use Committee in NIH. Five to 10 weeks old female or male mouse
adrenal glands were used for experiments to obtain chromafﬁn cells as described
previously65 with some modiﬁcation. Brieﬂy, adrenal glands were removed from
mice (two per culture) and bathed in a dissociation buffer containing (in mM): 80
Na-glutamate, 55 NaCl, 6 KCl, 1 MgCl2, 10 HEPES and 10 D-glucose pH 7 adjusted
with NaOH. Under a dissecting microscope, adrenal cortex was carefully removed
to expose the medulla. The medulla was ﬁrst digested in the dissociation buffering
containing papain (30Uml 1, Sigma), BSA (0.5mgml 1, Sigma) and
dithiothreitol (0.1mM, Sigma) at 37 C for 8min and further digested in the
dissociation buffer containing collagenase F (3Uml 1, Sigma) and CaCl2
(0.1mM) at 37 C. The digested medulla was carefully resuspended in DMEM
medium (Invitrogen) containing 10% fetal bovine serum (Gibco) and centrifuged
at 500 r.p.m. for 3min. For rescue experiments, Actb / cell pellet was transfected
with b-Actin–mEGFP (2 mg, Addgene) using a basic neuron nucleofector kit
(Lonza, Program O-005). For most other experiments, cell pellet was resuspended
in the fresh pre-warmed DMEM and plated onto poly-D-lysine and laminin
I-coated 25mm-diameter glass coverslips (Neuvitro Corp.). Cells were incubated at
37 C with 8% CO2 for at least 48 h before using for imaging or
immunocytochemistry. For immunocytochemistry, cultured cells were brieﬂy
washed with 1 PBS and ﬁxed with 4% paraformaldehyde (Electron Microscopy
Sciences, USA) in PBS for 20min. Cells were permeabilized with 0.5% Triton
X-100 for 10min, blocked with 5% goat serum before incubation with mouse
anti-b-actin (1/500, Abcam) and rabbit anti-Cre-recombinase antibodies (1/250,
Abcam) in PBS containing 0.1% Triton X-100 and 1% BSA at 4 C overnight. After
washing with PBS, cells were incubated with Atto-488- and Alexa-647-conjugated
secondary antibodies (1/400) in PBS containing 1% BSA, washed with PBS and
mounted. Images were examined by Zeiss LSM 510 meta confocal microscope.
Same image settings were applied to both control (WT or ActbLoxP/LoxP) and
b-actin KO mice chromafﬁn cells.
Micropipette aspiration measurements. A home-built micropipette aspiration
system with a graduated manometer was used for application of controlled suction
pressure onto living cells. Glass micropipettes with an inner diameter of 2–3 mm
were ﬁlled with 0.2% BSA in 1 PBS, to allow smooth movement of the cell
membrane inside the pipette. Negative pressure in the micropipette tip was gen-
erated by aspirating water from the manometer reservoir and increased gradually
in 200 Pa increments. Nikon Advanced Modulation Contrast optics mounted on a
Nikon Ti-S microscope and CoolSnap MYOCCD camera (Photometrics, Tucson,
AZ) were used to acquire live-cell bright-ﬁeld images. Image J (http://rsb.info.
nih.gov/ij/) software was used to manually measure the pipette diameters and
plasma membrane projection length within the pipette.
Atomic force microscopy. AFM imaging was performed on a BioScope Catalyst II
AFM with a Nanoscope V controller (Bruker, CA). A polystyrene microsphere with
known diameter of 9.6 mm (Interfacial Dynamics Corp., Portland, OR, USA) was
glued onto a tipless cantilever (MLCTO10-D, Bruker) whose spring constant is
calibrated by the standard thermal ﬂuctuation method. The cell volume was
obtained through the force volume mode in a scan range of 40 40mm with
64 64 pixels. The volume of the same cell was measured in control, in a
hyper-osmotic solution and in a hypo-osmotic solution under the same probe and
parameter setting for direct comparison. The resulting topographic images were
exported to ImageJ (version 1.49d, NIH, Bethesda, MD) for three-dimensional
visualization and cell-shape computation, and for ﬁnal volume ratio statistics and
plotting in Microsoft Excel (version 14, Richmond, WA).
Data collection and statistical analysis in chromafﬁn cells. All data at the
whole-cell conﬁguration were collected within 3min after whole-cell break-in,
which minimized whole-cell rundown of endocytosis11,66. All experiments in
chromafﬁn cells were carried out from at least three independent cultures.
Unpaired or paired Student’s t-test (two-tailed) was used for the statistical analysis.
The data were expressed as mean±s.e.m. or meanþ s.e.m.
Lamprey synapse and EM. Animal care and use were carried out in accordance
with Karolinska Institutet guidelines and approved by the Swedish Board of
Agriculture. Dissection of the trunk region of the lamprey spinal cord, micro-
injection procedures, stimulation and ﬁxation were performed as described
before67. Giant axons were stimulated at 5Hz for 20–30min using an extracellular
electrode. Action potentials in giant axons were monitored with an extracellular
suction electrode placed at the caudal part of the preparation (Supplementary
Fig. 12f). The microinjection pipettes contained latrunculin A (60 mM) and Cyto D
(33 mM), phalloidin-Alexa Flour 488 (1,200U ml 1; Invitrogen), PxA (5mgml 1)
and bovine proﬁlin I (5mgml 1) in a buffer solution containing 10mM HEPES
(pH 7.4), 250mMKþ acetate and 0.5% dimethyl sulfoxide. Covalently cross-linked
PxA was prepared as described previously33. Compounds were diluted in Texas
Red (3,000Mw, Molecular Probes) and monitored with a charge-coupled device
camera (Princeton Instruments) connected to a ﬂuorescence microscope and a
Nikon D-eclipse C1 confocal microscope using a  10 air or  40 water-
immersion objective (numerical aperture 0.80).
Synapses were studied for EM at distances larger than 100 mm from the site of
microinjections where the Texas Red ﬂuorescence was 10–20 times lower than at
the site of microinjection (Supplementary Fig. 12a). We therefore estimated that
the concentration of Lat A and Cyto D at the site of EM examination waso6 and
3.3 mM, respectively.
Spinal cords were ﬁxed during stimulation with 3% glutaraldehyde, 0.5%
paraformaldehyde in 0.1M cacodylate buffer (pH 7.4) containing 4% tannic acid
for 1 h, followed by the same ﬁxative without tannic acid for 3 h. After post ﬁxation
in 1% osmium tetroxide for 1 h and dehydration in alcohol, the specimens were
embedded in Durcupan ACM (Fluka). Serial ultrathin sections were cut with a
diamond knife (Diatome) and viewed at 80 kV in a Tecnai 12 electron microscope
(FEI).
Effects of microinjections were analyzed in synapses cut in serial ultrathin
sections. Samples were blinded before imaging and analysis. All described effects
were reproduced in at least two independent preparations in which one to six
axons were microinjected. Quantiﬁcations of fusion intermediates and synaptic
vesicles at the active zone were done from serial sections of ﬁve synapses.
Signiﬁcances and P-values were calculated using one-way analysis of variance
followed by Holm–Sˇı´da´k’s multiple comparisons test (GraphPad Prism 6).
For immunogold labelling experiments, non-stimulated lamprey spinal cords
were dissected, ﬁxed in 3% paraformaldehyde and 0.5% glutaraldehyde in 0.1M
cacodylate buffer (pH 7.4) containing 4% tannic acid for 1 h at 4 C, followed by
the same ﬁxative without tannic acid for 3 h. Specimens were stained en bloc with
2% uranyl acetate, dehydrated in graded ethanol series and embedded at  25 C
in LR Gold resin (Fluka). Serial ultrathin sections were collected on nickel mesh
grids and incubated overnight at 4 C with primary monoclonal actin antibodies
(b-actin Antibody (C4): sc-47778; Santa Cruz Biotech) diluted 1:100 in Tris-PBS
(pH 7.4) containing 1% human serum albumin and 5% BSA. Secondary antibodies
conjugated to 5 nm colloidal gold (AuroProbe EM GAM G5: RPN 424; Amersham
Biosciences) were used at a dilution of 1:25. Gold particles were enhanced using the
IntenSE Silver enhancement kit (RPN 492; Amersham Biosciences) following
manufacturer’s instructions. Sections were counterstained with uranyl acetate and
lead citrate, and examined in a Tecnai 12 electron microscope (FEI). Experiments
where primary antibodies were omitted did not produce any speciﬁc labelling. The
number of particles was quantiﬁed in selected regions (see Supplementary Fig. 13a)
and the density of gold particles per mm2 was calculated. Synapse was deﬁned as a
region containing synaptic vesicles clustered at dense projections at the presynaptic
membrane, the active zone.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles or are
available from the corresponding authors and the ﬁrst authors upon request.
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